
Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans
Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve
Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans
Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve
Ottawa biotech startup gets US$1M boost in quest to find treatment for muscle-wasting disease
Scientists at Satellos Bioscience are working on a drug that will help regenerate muscle tissue in patients who suffer from Duchenne muscular dystrophy.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.